Design Pharmaceuticals Closes $5 Million Pre-Series A Round To Accelerate Commercialization Of Ultrahigh Throughput Drug Discovery Platform
Apr 12, 2022•about 3 years ago
Amount Raised
$5 Million
Round Type
pre-series a
Description
Design Pharmaceuticals, a company redesigning small molecule drug discovery, today announced the closing of a pre-series A round of $5 million, including an investment of $3 million from Virtus Inspire Venture Partners. The proceeds will be used to further build the company’s discovery platform and operations. Design Pharmaceuticals’ platform is based on ultrahigh-throughput technologies that biomine drug-like molecules from natural sources, such as microbiota. These molecules are then evaluated at unprecedented speed and scale on hundreds of GPCR targets simultaneously.
FundzWatch™ Score
76
Medium Activity
Buyer Intent Analysis
Get personalized insights on buying likelihood